文献速递甲状腺与浅表头颈US

甲状腺结节超声:人工智能辅助诊断系统能否与细针穿刺相媲美?

US of thyroid nodules: can AI-assisted diagnostic system compete with fine needle aspiration?
PubMed 文献 · Eur Radiol · 2023-08-24

本研究在3家医院收集637个甲状腺结节的超声图像,比较人工智能诊断系统与细针穿刺细胞学单独及联合BRAFV600E突变分析的诊断效能;结果显示两种方法准确性无显著差异,人工智能系统对45个Bethesda III和IV类不确定结节也表现出较高灵敏度。

要点

  • 人工智能系统对45个Bethesda III和IV类不确定结节的准确率84.44%、灵敏度95.45%、特异度73.91%。
  • 回顾性队列346个结节和前瞻性多中心队列291个结节中,人工智能系统与细针穿刺细胞学联合BRAFV600E突变分析的准确性均无显著差异。
  • 人工智能系统在可操作性、时间效率、无创性和超声广泛可用性方面具有优势,为甲状腺结节诊断提供了新选择。

核心结论

  • 人工智能诊断系统与细针穿刺细胞学联合BRAFV600E突变分析对甲状腺结节的诊断性能相似。

研究设计与样本

  • 多中心研究,共收集3家医院637个甲状腺结节的超声图像;回顾性队列346个结节用于确定人工智能恶性阈值,前瞻性队列291个结节用于验证;金标准为术后病理或间隔半年两次细针穿刺联合突变分析均一致的良性结果。

诊断标准与关键数值

  • 人工智能系统恶性阈值根据回顾性队列346个结节的约登指数选取;对45个Bethesda III和IV类不确定结节,人工智能系统准确率84.44%、灵敏度95.45%、特异度73.91%。

临床应用与阅片要点

  • 甲状腺超声人工智能诊断系统在甲状腺结节筛查中可辅助放射科医师,并可能减少相对有创的细针穿刺活检需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Artificial intelligence (AI) systems can diagnose thyroid nodules with similar or better performance than radiologists. Little is known about how this performance compares with that achieved through fine needle aspiration (FNA). This study aims to compare the diagnostic yields of FNA cytopathology alone and combined with BRAFV600E mutation analysis and an AI diagnostic system.

METHODS: The ultrasound images of 637 thyroid nodules were collected in three hospitals. The diagnostic efficacies of an AI diagnostic system, FNA-based cytopathology, and BRAFV600E mutation analysis were evaluated in terms of sensitivity, specificity, accuracy, and the κ coefficient with respect to the gold standard, defined by postsurgical pathology and consistent benign outcomes from two combined FNA and mutation analysis examinations performed with a half-year interval.

RESULTS: The malignancy threshold for the AI system was selected according to the Youden index from a retrospective cohort of 346 nodules and then applied to a prospective cohort of 291 nodules. The combination of FNA cytopathology according to the Bethesda criteria and BRAFV600E mutation analysis showed no significant difference from the AI system in terms of accuracy for either cohort in our multicenter study. In addition, for 45 included indeterminate Bethesda category III and IV nodules, the accuracy, sensitivity, and specificity of the AI system were 84.44%, 95.45%, and 73.91%, respectively.

CONCLUSIONS: The AI diagnostic system showed similar diagnostic performance to FNA cytopathology combined with BRAFV600E mutation analysis. Given its advantages in terms of operability, time efficiency, non-invasiveness, and the wide availability of ultrasonography, it provides a new alternative for thyroid nodule diagnosis.

CLINICAL RELEVANCE STATEMENT: Thyroid ultrasonic artificial intelligence shows statistically equivalent performance for thyroid nodule diagnosis to FNA cytopathology combined with BRAFV600E mutation analysis. It can be widely applied in hospitals and clinics to assist radiologists in thyroid nodule screening and is expected to reduce the need for relatively invasive FNA biopsies.

KEY POINTS: • In a retrospective cohort of 346 nodules, the evaluated artificial intelligence (AI) system did not significantly differ from fine needle aspiration (FNA) cytopathology alone and combined with gene mutation analysis in accuracy. • In a prospective multicenter cohort of 291 nodules, the accuracy of the AI diagnostic system was not significantly different from that of FNA cytopathology either alone or combined with gene mutation analysis. • For 45 indeterminate Bethesda category III and IV nodules, the AI system did not perform significantly differently from BRAFV600E mutation analysis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhou T, Xu L, Shi J, et al. US of thyroid nodules: can AI-assisted diagnostic system compete with fine needle aspiration? Eur Radiol. 2023. PMID: 37615763. doi:10.1007/s00330-023-10132-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。